Duderstadt, Germany
Ottobock, with its slogan "Pioneering innovation to enhance quality of life with independence and freedom of movement," stands as a distinguished global MedTech leader. Founded in 1919 in Berlin, the company excels in prosthetics, neuro-orthotics, and exoskeletons, offering innovative solutions for those with limited mobility. Headquartered in Germany, Ottobock operates in 45 countries with a robust workforce of nearly 9,300 employees. The firm boasts an impressive portfolio, reflected in over 2,600 patents and applications, and maintains the largest international patient care network comprising about 400 clinics.
Recognized for its commitment to shaping the future of human bionics, Ottobock sustains a strong R&D focus. Their dedication to social impact is evidenced by a longstanding partnership with the Paralympics since 1988. Notably, the company's recent leadership includes a Secondary Market investment on 13 March 2024 by Hans Georg Näder and Nader Holding. This strategic move signals confidence in sustaining their market leadership and continuous innovation trajectory.
